Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $977.16 | 4 | 66.9% |
| Food and Beverage | $483.97 | 7 | 33.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,443 | 10 | $0 (2019) |
| Medtronic, Inc. | $17.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.82 | 1 | Medtronic, Inc. ($17.82) |
| 2019 | $891.59 | 7 | AstraZeneca Pharmaceuticals LP ($891.59) |
| 2018 | $551.72 | 3 | AstraZeneca Pharmaceuticals LP ($551.72) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Medtronic, Inc. | PTEYE PARATHYROID DETECTION SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Thyroid and Parathyroid Surgery Products | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $374.97 | General |
| Category: Oncology | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $281.99 | General |
| Category: Oncology | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $115.62 | General |
| Category: Oncology | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $47.83 | General |
| Category: Oncology | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $38.48 | General |
| Category: Oncology | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Oncology | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Oncology | ||||||
| 11/06/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $281.72 | General |
| Category: Oncology | ||||||
| 11/06/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 11/06/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 152 | 157 | $132,215 | $30,668 |
| 2022 | 4 | 185 | 186 | $210,635 | $49,088 |
| 2021 | 5 | 207 | 213 | $295,510 | $66,511 |
| 2020 | 4 | 129 | 131 | $141,005 | $34,104 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 60500 | Removal or exploration of parathyroid glands | Facility | 2023 | 26 | 26 | $93,600 | $18,454 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $24,795 | $7,289 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 50 | $7,845 | $3,240 | 41.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $5,975 | $1,685 | 28.2% |
| 60500 | Removal or exploration of parathyroid glands | Facility | 2022 | 48 | 48 | $170,280 | $35,925 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $28,105 | $8,765 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 45 | $6,750 | $2,804 | 41.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $5,500 | $1,593 | 29.0% |
| 60500 | Removal or exploration of parathyroid glands | Facility | 2021 | 46 | 46 | $164,880 | $34,904 | 21.2% |
| 60252 | Removal of thyroid and surrounding lymph nodes, with limited neck dissection | Facility | 2021 | 17 | 17 | $88,200 | $17,541 | 19.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $24,255 | $8,132 | 33.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 41 | 41 | $11,275 | $3,049 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 46 | $6,900 | $2,886 | 41.8% |
| 60500 | Removal or exploration of parathyroid glands | Facility | 2020 | 34 | 34 | $115,930 | $26,053 | 22.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 36 | 36 | $13,500 | $4,221 | 31.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 37 | 39 | $5,655 | $1,958 | 34.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $5,920 | $1,872 | 31.6% |
About Dr. William Gillanders, MD
Dr. William Gillanders, MD is a Surgical Oncology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720006364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Gillanders, MD has received a total of $1,461 in payments from pharmaceutical and medical device companies, with $17.82 received in 2024. These payments were reported across 11 transactions from 2 companies. The most common payment nature is "Travel and Lodging" ($977.16).
As a Medicare-enrolled provider, Gillanders has provided services to 673 Medicare beneficiaries, totaling 687 services with total Medicare billing of $180,371. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Surgical Oncology
- Location Saint Louis, MO
- Active Since 07/18/2006
- Last Updated 04/17/2025
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1720006364
Products in Payments
- IMFINZI (Drug) $1,443
- PTEYE PARATHYROID DETECTION SYSTEM (Device) $17.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Saint Louis
Dr. Peter Dipasco, Md, MD
Surgical Oncology — Payments: $198,694
Dr. Julie Margenthaler, Md, MD
Surgical Oncology — Payments: $35,371
Dr. Trang Nguyen, Md, MD
Surgical Oncology — Payments: $10,071
Dr. Rebecca Aft, Md, MD
Surgical Oncology — Payments: $9,898
Dr. Roheena Panni, Md, MD
Surgical Oncology — Payments: $3,618
Dr. Ashton Brooks, Md, MD
Surgical Oncology — Payments: $937.54